Accent Therapeutics Competitors and Similar CompaniesClear all

Accent Therapeutics's competitors and similar companies include Lupagen, Courier Therapeutics, Kyowa Kirin and Takeda.
Accent Therapeutics
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company engaged in the development of therapies for cancer.
Lupagen
Lupagen
Lupagen is a medical device company specializing in cell and gene therapies.
Courier Therapeutics
Courier Therapeutics
Courier Therapeutics is a biotechnology company providing a cytotoxic-lymphocyte targeting therapy platform.
Kyowa Kirin
Kyowa Kirin
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
Takeda
Takeda
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
Founding Date
Founding Date
2017
Founding Date
2017
Founding Date
2015
Founding Date
2008
Founding Date
1781
Type
Type
Private
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Lexington, US HQ
Locations
Dallas, US HQ
Locations
Houston, US HQ
Houston, US
Locations
Tokyo, JP HQ
Sydney, AU
Shanghai, CN
Prague, CZ
Tampere, FI
Düsseldorf, DE
Hong Kong, HK
see more
Locations
Tokyo, JP HQ
Buenos Aires, AR
The Rocks, AU
Linz, AT
Wien, AT
Wien, AT
Lessines, BE
see more
Employees
Employees
4616% decrease
Employees
2
Employees
1
Employees
5,974
Employees
49,281
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
8.8 b
Valuation ($)
43.7 b

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
¥442.2b (FY, 2023)
Revenue (est.)
¥4.3t (FY, 2024)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
¥90.1b (FY, 2023)
Cost of goods
¥698.7b (FY, 2024)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
¥368.9b (FY, 2023)
Gross profit
¥3.6t (FY, 2024)
Net income
Net income
N/A
Net income
N/A
Net income
N/A
Net income
¥81.2b (FY, 2023)
Net income
¥144.2b (FY, 2024)

Funding

Total funding raised
Total funding raised
$ 103m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 57.8m
For sources of this data, please see the company profile

View Company Profiles

Lupagen
HQ
Dallas, US
Employees
2

Lupagen is a medical device company specializing in cell and gene therapies.

View company
Courier Therapeutics
HQ
Houston, US
Employees
1

Courier Therapeutics is a biotechnology company providing a cytotoxic-lymphocyte targeting therapy platform.

View company
Kyowa Kirin
HQ
Tokyo, JP
Employees
5,974

Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.

View company
Takeda
HQ
Tokyo, JP
Employees
49,281

Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.

View company